Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Recruiting 12Not yet recruiting 5Completed 4Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Colorectal Neoplasms 296Carcinoma, Hepatocellular 212Stomach Neoplasms 155Pancreatic Neoplasms 155Rectal Neoplasms 114Esophageal Neoplasms 84Colonic Neoplasms 78Esophageal Squamous Cell Carcinoma 51Cholangiocarcinoma 48Liver Neoplasms 46Biliary Tract Neoplasms 36Neoplasms 31Breast Neoplasms 31Neoplasm Metastasis 28Gastrointestinal Neoplasms 26Carcinoma, Non-Small-Cell Lung 26Lung Neoplasms 20Disease 18Prostatic Neoplasms 17Uterine Cervical Neoplasms 16Recurrence 16Ovarian Neoplasms 14Colorectal Neoplasms, Hereditary Nonpolyposis 13Endometrial Neoplasms 12Head and Neck Neoplasms 11Adenocarcinoma Of Esophagus 11Gallbladder Neoplasms 10Colonic Polyps 10Anus Neoplasms 10Melanoma 9

Interventions

nimotuzumab 2surufatinib 1Hematologic Tests 1Gemcitabine 1Blood Specimen Collection 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Pancreatic cancer, adult × Gastrointestinal × Clear all
NCT07529626 2026-04-14

MIND-PANC

Shanghai Zhongshan Hospital

Not yet recruiting
320 enrolled
Gastrointestinal

Pancreatic cancer, adult, Anxiety Disorders, Depression, Pancreatic Neoplasms, Disease Progression

NCT07436741 2026-02-27

Surufatinib Plus Gemcitabine and Nab-paclitaxel vs. Gemcitabine Plus Nab-paclitaxel in Neoadjuvant Therapy for High - Risk Resectable or Borderline Resectable Pancreatic Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 3 Not yet recruiting
106 enrolled
Gastrointestinal

Pancreatic cancer, adult

NCT07277452 2025-12-11

NOTABLE-309

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Not yet recruiting
156 enrolled
Gastrointestinal

Pancreatic cancer, adult

NCT06938503 2025-04-22

AG Plus Nimotuzumab Sequential Irreversible Electroporation Ablation for Locally Advanced Pancreatic Cancer

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
48 enrolled
Gastrointestinal

Pancreatic cancer, adult

NCT06760741 2025-01-07

PREVENPANC

Hospital Clinic of Barcelona

Not yet recruiting
900 enrolled
Gastrointestinal

Pancreatic cancer, adult, Pancreatic carcinoma, familial, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡